About Us
Login
Retail Customer Login
Business User Login
Registration
Retail Customer Registration
Business User Registration
0
Shop Products
Ambulatory Equipment
Apparel
Appliances (Durable Goods)
Body Pressure Relief and Positioning
Clinical Laboratory
Diagnostic Instruments and Supplies
Drainage and Suction
Furnishings
Gloves
Housekeeping
Implants
Incontinence
Indicators and Signage
Instruments
IV Therapy
Needles and Syringes
Nurse's Station and Office Supplies
Nutritionals and Feeding Supplies
Orthopedic
Ostomy
other
Personal Hygiene
Pharmaceuticals
Physical Therapy
Respiratory
Services
Sterilization
Textiles
Training and Education
Urological
Utensils
Ventilators
Wound Care
Wound Closure
0
Retail Customer Login
Business User Login
Retail Customer Registration
Business User Registration
Shop Products
Ambulatory Equipment
Apparel
Appliances (Durable Goods)
Body Pressure Relief and Positioning
Clinical Laboratory
Diagnostic Instruments and Supplies
Drainage and Suction
Furnishings
Gloves
Housekeeping
Implants
Incontinence
Indicators and Signage
Instruments
IV Therapy
Needles and Syringes
Nurse's Station and Office Supplies
Nutritionals and Feeding Supplies
Orthopedic
Ostomy
other
Personal Hygiene
Pharmaceuticals
Physical Therapy
Respiratory
Services
Sterilization
Textiles
Training and Education
Urological
Utensils
Ventilators
Wound Care
Wound Closure
$
Go Back
Cbl0137
/=95% 1197996-80-7 Crystal 1Mg. CBL0137, Purity
/=95%, CAS 1197996-80-7, MF: C21H24N2O2, MW: 336.4, Synonyms: CBLC137, Curaxin 137, 1,1'-[9-[2-[(1-methylethyl)amino]ethyl]-9H-carbazole-3,6-diyl]bis-ethanone, Formulation: A crystalline solid, Storage: -20C, Size: 1mg
Cbl0137
/=95% 1197996-80-7 Crystal 5Mg. CBL0137, Purity
/=95%, CAS 1197996-80-7, MF: C21H24N2O2, MW: 336.4, Synonyms: CBLC137, Curaxin 137, 1,1'-[9-[2-[(1-methylethyl)amino]ethyl]-9H-carbazole-3,6-diyl]bis-ethanone, Formulation: A crystalline solid, Storage: -20C, Size: 5mg
Cbl0137
/=95% 1197996-80-7 Crystal 10Mg. CBL0137, Purity
/=95%, CAS 1197996-80-7, MF: C21H24N2O2, MW: 336.4, Synonyms: CBLC137, Curaxin 137, 1,1'-[9-[2-[(1-methylethyl)amino]ethyl]-9H-carbazole-3,6-diyl]bis-ethanone, Formulation: A crystalline solid, Storage: -20C, Size: 10mg
Cid-2858522 98% 758679-97-9 Crystal 1Mg. CID-2858522, Purity
/=98%, CAS 758679-97-9, MF: C28H39N3O3, MW: 465.6, Synonyms: ML-029, 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dimethyl-1H-benzimidazol-1-yl]-ethanone, Formulation: A crystalline solid, Size: 1mg
Cid-2858522 98% 758679-97-9 Crystal 5Mg. CID-2858522, Purity
/=98%, CAS 758679-97-9, MF: C28H39N3O3, MW: 465.6, Synonyms: ML-029, 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dimethyl-1H-benzimidazol-1-yl]-ethanone, Formulation: A crystalline solid, Size: 5mg
Cid-2858522 98% 758679-97-9 Crystal 10Mg. CID-2858522, Purity
/=98%, CAS 758679-97-9, MF: C28H39N3O3, MW: 465.6, Synonyms: ML-029, 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dimethyl-1H-benzimidazol-1-yl]-ethanone, Formulation: A crystalline solid, Size: 10mg
Cid-2858522 98% 758679-97-9 Crystal 25Mg. CID-2858522, Purity
/=98%, CAS 758679-97-9, MF: C28H39N3O3, MW: 465.6, Synonyms: ML-029, 1-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dimethyl-1H-benzimidazol-1-yl]-ethanone, Formulation: A crystalline solid, Size: 25mg
Jsh-23
/=98% 749886-87-1 Crystal 1Mg. JSH-23, Purity
/=98%, CAS 749886-87-1, MF: C16H20N2, MW: 240.3, Synonyms: NF-KB Activation Inhibitor II, 4-methyl-N1-(3-phenylpropyl)-1,2-benzenediamine, Formulation: A crystalline solid, Storage: -20C, Size: 1mg
Jsh-23
/=98% 749886-87-1 Crystal 5Mg. JSH-23, Purity
/=98%, CAS 749886-87-1, MF: C16H20N2, MW: 240.3, Synonyms: NF-KB Activation Inhibitor II, 4-methyl-N1-(3-phenylpropyl)-1,2-benzenediamine, Formulation: A crystalline solid, Storage: -20C, Size: 5mg
Jsh-23
/=98% 749886-87-1 Crystal 10Mg. JSH-23, Purity
/=98%, CAS 749886-87-1, MF: C16H20N2, MW: 240.3, Synonyms: NF-KB Activation Inhibitor II, 4-methyl-N1-(3-phenylpropyl)-1,2-benzenediamine, Formulation: A crystalline solid, Storage: -20C, Size: 10mg
Jsh-23
/=98% 749886-87-1 Crystal 25Mg. JSH-23, Purity
/=98%, CAS 749886-87-1, MF: C16H20N2, MW: 240.3, Synonyms: NF-KB Activation Inhibitor II, 4-methyl-N1-(3-phenylpropyl)-1,2-benzenediamine, Formulation: A crystalline solid, Storage: -20C, Size: 25mg
Nf-+b Activation Inhibitor Iii 99% 5Mg. NF-KB Activation Inhibitor III, Purity
/=99%, CAS 380623-76-7, MF: C10H5ClN4O5S, MW: 328.7, Synonyms: SM-7368, 3-chloro-4-nitro-N-(5-nitro-2-thiazolyl)-benzamide, Formulation: A crystalline solid, Storage: -20C, Size: 5mg
Nf-+b Activation Inhibitor Iii 99% 25Mg. NF-KB Activation Inhibitor III, Purity
/=99%, CAS 380623-76-7, MF: C10H5ClN4O5S, MW: 328.7, Synonyms: SM-7368, 3-chloro-4-nitro-N-(5-nitro-2-thiazolyl)-benzamide, Formulation: A crystalline solid, Storage: -20C, Size: 25mg
Nf-+b Inhibitor
/=95% 213546-53-3 500Ug. NF-KB Inhibitor, Purity
/=95%, CAS 213546-53-3, MF: C129H230N36O29S, MW: 2781.5, Synonyms: SN50 Peptide, synthetic peptide corresponding to the nuclear localization sequence of NF-KB p105 subunit, Formulation: A crystalline solid, Storage: -20C, Size: 500ug
Nf-+b Inhibitor
/=95% 213546-53-3 1Mg. NF-KB Inhibitor, Purity
/=95%, CAS 213546-53-3, MF: C129H230N36O29S, MW: 2781.5, Synonyms: SN50 Peptide, synthetic peptide corresponding to the nuclear localization sequence of NF-KB p105 subunit, Formulation: A crystalline solid, Storage: -20C, Size: 1mg
Nf-+b Inhibitor
/=95% 213546-53-3 5Mg. NF-KB Inhibitor, Purity
/=95%, CAS 213546-53-3, MF: C129H230N36O29S, MW: 2781.5, Synonyms: SN50 Peptide, synthetic peptide corresponding to the nuclear localization sequence of NF-KB p105 subunit, Formulation: A crystalline solid, Storage: -20C, Size: 5mg
Ikk2 Inhibitor Vi 95% 354811-10-2 500Ug. IKK2 Inhibitor VI, Purity
/=95%, CAS 354811-10-2, MF: C12H11N3O2S, MW: 261.3, Synonyms: 5-Phenyl-2-ureidothiophene-3-carboxylic Acid Amide, 2-[(aminocarbonyl)amino]-5-phenyl-3-thiophenecarboxamide, Formulation: A crystalline solid, Storage: -20C, Size: 500ug
Ikk2 Inhibitor Vi
/=95% 354811-10-2 1Mg. IKK2 Inhibitor VI, Purity
/=95%, CAS 354811-10-2, MF: C12H11N3O2S, MW: 261.3, Synonyms: 5-Phenyl-2-ureidothiophene-3-carboxylic Acid Amide, 2-[(aminocarbonyl)amino]-5-phenyl-3-thiophenecarboxamide, Formulation: A crystalline solid, Storage: -20C, Size: 1mg
Ikk2 Inhibitor Vi
/=95% 354811-10-2 5Mg. IKK2 Inhibitor VI, Purity
/=95%, CAS 354811-10-2, MF: C12H11N3O2S, MW: 261.3, Synonyms: 5-Phenyl-2-ureidothiophene-3-carboxylic Acid Amide, 2-[(aminocarbonyl)amino]-5-phenyl-3-thiophenecarboxamide, Formulation: A crystalline solid, Storage: -20C, Size: 5mg
Ikk-16 (Hydrochloride) 98% Crystal 5Mg. IKK-16 (hydrochloride), Purity
/=98%, CAS 1186195-62-9, MF: C28H29N5OS.HCl, MW: 520.1, Synonyms: IKK Inhibitor VII, [4-[(4-benzo[b]thien-2-yl-2-pyrimidinyl)amino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]-methanone, monohydrochloride, crystalline, Size: 5mg
Ikk-16 (Hydrochloride) 98% Crystal 10Mg. IKK-16 (hydrochloride), Purity
/=98%, CAS 1186195-62-9, MF: C28H29N5OS.HCl, MW: 520.1, Synonyms: IKK Inhibitor VII, [4-[(4-benzo[b]thien-2-yl-2-pyrimidinyl)amino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]-methanone, monohydrochloride, crystalline, Size: 10mg
Ikk-16 (Hydrochloride) 98% Crystal 25Mg. IKK-16 (hydrochloride), Purity
/=98%, CAS 1186195-62-9, MF: C28H29N5OS.HCl, MW: 520.1, Synonyms: IKK Inhibitor VII, [4-[(4-benzo[b]thien-2-yl-2-pyrimidinyl)amino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]-methanone, monohydrochloride, crystalline, Size: 25mg
Ikk-16 (Hydrochloride) 98% Crystal 50Mg. IKK-16 (hydrochloride), Purity
/=98%, CAS 1186195-62-9, MF: C28H29N5OS.HCl, MW: 520.1, Synonyms: IKK Inhibitor VII, [4-[(4-benzo[b]thien-2-yl-2-pyrimidinyl)amino]phenyl][4-(1-pyrrolidinyl)-1-piperidinyl]-methanone, monohydrochloride, crystalline, Size: 50mg
Imd 0354
/=98% Cas 978-62-1 Crystal 1Mg. IMD 0354, Purity
/=98%, CAS 978-62-1, MF: C15H8ClF6NO2, MW: 383.7, Synonyms: IKK2 Inhibitor V, N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy-benzamide, Formulation: A crystalline solid, Size: 50mg
Imd 0354
/=98% Cas 978-62-1 Crystal 5Mg. IMD 0354, Purity
/=98%, CAS 978-62-1, MF: C15H8ClF6NO2, MW: 383.7, Synonyms: IKK2 Inhibitor V, N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy-benzamide, Formulation: A crystalline solid, Size: 5mg
Imd 0354
/=98% 978-62-1 Crystal 10Mg. IMD 0354, Purity
/=98%, CAS 978-62-1, MF: C15H8ClF6NO2, MW: 383.7, Synonyms: IKK2 Inhibitor V, N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy-benzamide, Formulation: A crystalline solid, Size: 10mg
Imd 0354
/=98% 978-62-1 Crystal 50Mg. IMD 0354, Purity
/=98%, CAS 978-62-1, MF: C15H8ClF6NO2, MW: 383.7, Synonyms: IKK2 Inhibitor V, N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy-benzamide, Formulation: A crystalline solid, Size: 50mg
Ly2409881
/=98% Cas No 946518-60-1 1Mg. LY2409881, Purity
/=98%, CAS 946518-60-1, MF: C24H29ClN6OS.3HCl, MW: 594.4, Synonyms: 2-[5-chloro-2-[[3-(4-methyl-1-piperazinyl)propyl]amino]-4-pyrimidinyl]-N-cyclopropyl-benzo[b]thiophene-4-carboxamide, trihydrochloride, Formulation: crystalline, Size: 1mg
Ly2409881
/=98% Cas No 946518-60-1 5Mg. LY2409881, Purity
/=98%, CAS 946518-60-1, MF: C24H29ClN6OS.3HCl, MW: 594.4, Synonyms: 2-[5-chloro-2-[[3-(4-methyl-1-piperazinyl)propyl]amino]-4-pyrimidinyl]-N-cyclopropyl-benzo[b]thiophene-4-carboxamide, trihydrochloride, Formulation: crystalline, Size: 5mg
Ly2409881
/=98% Cas No 946518-60-1 10Mg. LY2409881, Purity
/=98%, CAS 946518-60-1, MF: C24H29ClN6OS.3HCl, MW: 594.4, Synonym: 2-[5-chloro-2-[[3-(4-methyl-1-piperazinyl)propyl]amino]-4-pyrimidinyl]-N-cyclopropyl-benzo[b]thiophene-4-carboxamide, trihydrochloride, Formulation: crystal, Size: 10mg
Ly2409881
/=98% Cas No 946518-60-1 25Mg. LY2409881, Purity
/=98%, CAS 946518-60-1, MF: C24H29ClN6OS.3HCl, MW: 594.4, Synonym: 2-[5-chloro-2-[[3-(4-methyl-1-piperazinyl)propyl]amino]-4-pyrimidinyl]-N-cyclopropyl-benzo[b]thiophene-4-carboxamide, trihydrochloride, Formulation: crystal, Size: 25mg
Sc-514
/=98% 354812-17-2 Crystal 5Mg. SC-514, Purity
/=98%, CAS 354812-17-2, MF: C9H8N2OS2, MW: 224.3, Synonyms: 4-amino-[2,3'-bithiophene]-5-carboxamide, selective and reversible inhibitor of IKB kinase 2, Formulation: A crystalline solid, Size: 5mg
Sc-514
/=98% 354812-17-2 Crystal 10Mg. SC-514, Purity
/=98%, CAS 354812-17-2, MF: C9H8N2OS2, MW: 224.3, Synonyms: 4-amino-[2,3'-bithiophene]-5-carboxamide, selective and reversible inhibitor of IKB kinase 2, Formulation: A crystalline solid, Size: 10mg
Sc-514
/=98% 354812-17-2 Crystal 25Mg. SC-514, Purity
/=98%, CAS 354812-17-2, MF: C9H8N2OS2, MW: 224.3, Synonyms: 4-amino-[2,3'-bithiophene]-5-carboxamide, selective and reversible inhibitor of IKB kinase 2, Formulation: A crystalline solid, Size: 25mg
Sc-514
/=98% 354812-17-2 Crystal 50Mg. SC-514, Purity
/=98%, CAS 354812-17-2, MF: C9H8N2OS2, MW: 224.3, Synonyms: 4-amino-[2,3'-bithiophene]-5-carboxamide, selective and reversible inhibitor of IKB kinase 2, Formulation: A crystalline solid, Size: 50mg
Tpca-1
/=98% 507475-17-4 Crystal 500Ug. TPCA-1, Purity
/=98%, CAS 507475-17-4, MF: C12H10FN3O2S, MW: 279.3, Synonyms: IKK2 Inhibitor IV2, 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide, Formulation: A crystalline solid, Size: 500ug
Tpca-1
/=98% 507475-17-4 Crystal 1Mg. TPCA-1, Purity
/=98%, CAS 507475-17-4, MF: C12H10FN3O2S, MW: 279.3, Synonyms: IKK2 Inhibitor IV2, 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide, Formulation: A crystalline solid, Size: 1mg
Tpca-1
/=98% 507475-17-4 Crystal 5Mg. TPCA-1, Purity
/=98%, CAS 507475-17-4, MF: C12H10FN3O2S, MW: 279.3, Synonyms: IKK2 Inhibitor IV2, 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide, Formulation: A crystalline solid, Size: 5mg
Tpca-1
/=98% 507475-17-4 Crystal 10Mg. TPCA-1, Purity
/=98%, CAS 507475-17-4, MF: C12H10FN3O2S, MW: 279.3, Synonyms: IKK2 Inhibitor IV2, 2-[(aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide, Formulation: A crystalline solid, Size: 10mg
Avenanthramide-C Methyl Ester
90% 500Ug. Avenanthramide-C methyl ester, Purity
/=90%, CAS 955382-52-2, MF: C17H15NO6, MW: 329.3, Synonyms: 2-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]amino]5-hydroxy-benzoic acid, methyl ester, Formulation: A crystalline solid, Size: 500ug
Avenanthramide-C Methyl Ester
/=90% 1Mg. Avenanthramide-C methyl ester, Purity
/=90%, CAS 955382-52-2, MF: C17H15NO6, MW: 329.3, Synonyms: 2-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]amino]5-hydroxy-benzoic acid, methyl ester, Formulation: A crystalline solid, Size: 1mg
Avenanthramide-C Methyl Ester
/=90% 5Mg. Avenanthramide-C methyl ester, Purity
/=90%, CAS 955382-52-2, MF: C17H15NO6, MW: 329.3, Synonyms: 2-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]amino]5-hydroxy-benzoic acid, methyl ester, Formulation: A crystalline solid, Size: 5mg
Avenanthramide-C Methyl Ester
90% 10Mg. Avenanthramide-C methyl ester, Purity
/=90%, CAS 955382-52-2, MF: C17H15NO6, MW: 329.3, Synonyms: 2-[[(2E)-3-(3,4-dihydroxyphenyl)-1-oxo-2-propen-1-yl]amino]5-hydroxy-benzoic acid, methyl ester, Formulation: A crystalline solid, Size: 10mg
Bay 11-7082
/=98% Cas 19542-67-7 5Mg. BAY 11-7082, Purity
/=98%, CAS 19542-67-7, MF: C10H9NO2S, MW: 207.3, Synonyms: 3-[(4-methylphenyl)sulfonyl]-(2E)-propenenitrile, plays a key role in regulating over 150 target genes including the expression of inflammatory cytokines, crystalline, Size: 10mg
Bay 11-7082
/=98% Cas 19542-67-7 10Mg. BAY 11-7082, Purity
/=98%, CAS 19542-67-7, MF: C10H9NO2S, MW: 207.3, Synonyms: 3-[(4-methylphenyl)sulfonyl]-(2E)-propenenitrile, plays a key role in regulating over 150 target genes including the expression of inflammatory cytokines, crystalline, Size: 10mg
Ppm-18
/=95% Cas 65240-86-0 Crystal 1Mg. PPM-18, Purity
/=95%, CAS 65240-86-0, MF: C17H11NO3, MW: 277.3, Synonyms: NSC 73233, N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide, naphthoquinone compound that inhibits NF-KB activation in vitro and in vivo, Formulation: A crystalline solid, Size: 1mg
Ppm-18
/=95% Cas 65240-86-0 Crystal 5Mg. PPM-18, Purity
/=95%, CAS 65240-86-0, MF: C17H11NO3, MW: 277.3, Synonyms: NSC 73233, N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide, naphthoquinone compound that inhibits NF-KB activation in vitro and in vivo, Formulation: A crystalline solid, Size: 5mg
Ppm-18
/=95% 65240-86-0 Crystal 10Mg. PPM-18, Purity
/=95%, CAS 65240-86-0, MF: C17H11NO3, MW: 277.3, Synonyms: NSC 73233, N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide, naphthoquinone compound that inhibits NF-KB activation in vitro and in vivo, Formulation: A crystalline solid, Size: 10mg
Ppm-18
/=95% 65240-86-0 Crystal 25Mg. PPM-18, Purity
/=95%, CAS 65240-86-0, MF: C17H11NO3, MW: 277.3, Synonyms: NSC 73233, N-(1,4-dihydro-1,4-dioxo-2-naphthalenyl)-benzamide, naphthoquinone compound that inhibits NF-KB activation in vitro and in vivo, Formulation: A crystalline solid, Size: 25mg
Qnz
/=98% Cas Number 545380-34-5 500Ug. QNZ, Purity
/=98%, CAS 545380-34-5, MF: C22H20N4O, MW: 356.4, Synonyms: CAY10470, N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine, ubiquitous transcription factor that functions to enhance the transcription of pro-inflammatory cytokine, Size: 500ug
Qnz
/=98% Cas Number 545380-34-5 1Mg. QNZ, Purity
/=98%, CAS 545380-34-5, MF: C22H20N4O, MW: 356.4, Synonyms: CAY10470, N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine, ubiquitous transcription factor that functions to enhance the transcription of pro-inflammatory cytokine, Size: 1mg
Qnz
/=98% Cas Number 545380-34-5 5Mg. QNZ, Purity
/=98%, CAS 545380-34-5, MF: C22H20N4O, MW: 356.4, Synonyms: CAY10470, N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine, ubiquitous transcription factor that functions to enhance the transcription of pro-inflammatory cytokine, Size: 5mg
Qnz
/=98% Cas Number 545380-34-5 10Mg. QNZ, Purity
/=98%, CAS 545380-34-5, MF: C22H20N4O, MW: 356.4, Synonyms: CAY10470, N4-[2-(4-phenoxyphenyl)ethyl]-4,6-quinazolinediamine, ubiquitous transcription factor that functions to enhance the transcription of pro-inflammatory cytokine, Size: 10mg
Wedelolactone
/=98% Cas 524-12-9 500Ug. Wedelolactone, Purity
/=98%, CAS 524-12-9, MF: C16H10O7, MW: 314.3, Synonyms: IKK Inhibitor II, 1,8,9-trihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one, natural coumestan originally isolated from plants used in herbal therapies, Size: 10mg
Wedelolactone
/=98% Cas 524-12-9 1Mg. Wedelolactone, Purity
/=98%, CAS 524-12-9, MF: C16H10O7, MW: 314.3, Synonyms: IKK Inhibitor II, 1,8,9-trihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one, natural coumestan originally isolated from plants used in herbal therapies, Size: 10mg
Wedelolactone
/=98% Cas 524-12-9 5Mg. Wedelolactone, Purity
/=98%, CAS 524-12-9, MF: C16H10O7, MW: 314.3, Synonyms: IKK Inhibitor II, 1,8,9-trihydroxy-3-methoxy-6H-benzofuro[3,2-c][1]benzopyran-6-one, natural coumestan originally isolated from plants used in herbal therapies, Size: 10mg
Bay 11-7082
/=98% Cas 19542-67-7 25Mg. BAY 11-7082, Purity
/=98%, CAS 19542-67-7, MF: C10H9NO2S, MW: 207.3, Synonyms: 3-[(4-methylphenyl)sulfonyl]-(2E)-propenenitrile, plays a key role in regulating over 150 target genes including the expression of inflammatory cytokine, crystalline, Size: 25mg
Bay 11-7082
/=98% Cas 19542-67-7 50Mg. BAY 11-7082, Purity
/=98%, CAS 19542-67-7, MF: C10H9NO2S, MW: 207.3, Synonyms: 3-[(4-methylphenyl)sulfonyl]-(2E)-propenenitrile, plays a key role in regulating over 150 target genes including the expression of inflammatory cytokine, crystalline, Size: 50mg
Caffeic Acid Phenylethyl Ester 98% 50Mg. Caffeic Acid phenylethyl ester, Purity
/=98%, CAS 104594-70-9, MF: C17H16O4, MW: 284.3, Synonyms: CAPE, 2-Phenylethyl Caffeate, B-Phenylethyl Caffeate, (E)-3-(3,4-dihydroxyphenyl)-2-propenoic acid, 2-phenylethyl ester, Formulation: crystalline, Size: 50mg
Caffeic Acid Phenylethyl Ester 98% 100Mg. Caffeic Acid phenylethyl ester, Purity
/=98%, CAS 104594-70-9, MF: C17H16O4, MW: 284.3, Synonyms: CAPE, 2-Phenylethyl Caffeate, B-Phenylethyl Caffeate, (E)-3-(3,4-dihydroxyphenyl)-2-propenoic acid, 2-phenylethyl ester, Formulation: crystalline, Size: 100mg
Caffeic Acid Phenylethyl Ester 98% 500Mg. Caffeic Acid phenylethyl ester, Purity
/=98%, CAS 104594-70-9, MF: C17H16O4, MW: 284.3, Synonyms: CAPE, 2-Phenylethyl Caffeate, B-Phenylethyl Caffeate, (E)-3-(3,4-dihydroxyphenyl)-2-propenoic acid, 2-phenylethyl ester, Formulation: crystalline, Size: 500mg
Cyclic Di-Amp (Sodium Salt)
/=98% 500Ug. Cyclic di-AMP (sodium salt), Purity:
/=98%, A second messenger produced by bacteria, but not by mammals, Synonyms: c-di-AMP, Cyclic di-Adenosine monophosphate, 3',5'-Cyclic diadenylic acid, Cyclic diadenylate, Size: 500ug
Cyclic Di-Amp (Sodium Salt)
/=98% 1Mg. Cyclic di-AMP (sodium salt), Purity:
/=98%, A second messenger produced by bacteria, but not by mammals, Synonyms: c-di-AMP, Cyclic di-Adenosine monophosphate, 3',5'-Cyclic diadenylic acid, Cyclic diadenylate, Size: 1mg
Cyclic Di-Amp (Sodium Salt)
/=98% 5Mg. Cyclic di-AMP (sodium salt), Purity:
/=98%, A second messenger produced by bacteria, but not by mammals, Synonyms: c-di-AMP, Cyclic di-Adenosine monophosphate, 3',5'-Cyclic diadenylic acid, Cyclic diadenylate, Size: 5mg
Cyclic Di-Gmp (Sodium Salt)
/=95% 500Ug. Cyclic di-GMP (sodium salt), Purity:
/=95%, Cas number: 2222132-40-1, Molecular Formula: C20H22N10O14P2.2Na, Molecular Weight: 734.4 g/mol, Appearance: A solid, Synonyms: 3',5'-Cyclic diguanylic acid, Guanylyl-(3'G5')-3'-guanylic acid, Size: 500ug
Cyclic Di-Gmp (Sodium Salt)
/=95% 1Mg. Cyclic di-GMP (sodium salt), Purity:
/=95%, Cas number: 2222132-40-1, Molecular Formula: C20H22N10O14P2.2Na, Molecular Weight: 734.4 g/mol, Appearance: A solid, Synonyms: 3',5'-Cyclic diguanylic acid, Guanylyl-(3'G5')-3'-guanylic acid, Size: 1mg
Cyclic Di-Imp (Sodium Salt)
/=95% 500Ug. Cyclic di-IMP (sodium salt), Purity:
/=95%, A synthetic second messenger; has mucosal adjuvant properties in vitro and in vivo by the mucosal route, Synonyms: Cyclic di-inosine monophosphate, c-di-IMP, Appearance: A crystalline solid, Size: 500ug
Cyclic Di-Imp (Sodium Salt)
/=95% 1Mg. Cyclic di-IMP (sodium salt), Purity:
/=95%, A synthetic second messenger; has mucosal adjuvant properties in vitro and in vivo by the mucosal route, Synonyms: Cyclic di-inosine monophosphate, c-di-IMP, Appearance: A crystalline solid, Size: 1mg
2 2-Cgamp
/=98% Cas 1465774-27-9 500Ug. 2 2-cGAMP, Purity:
/=98%, Cas number: 1465774-27-9, Molecular Formula: C20H24N10O13P2, Molecular Weight: 674.4 g/mol, Synonyms: 2,2 -Cyclic GMP-AMP, Adenosine-Guanosine 2,2 -cyclic monophosphate, adenylyl-(2 G 5 )-2 -guanylic acid, Size: 500ug
2 2-Cgamp
/=98% Cas 1465774-27-9 1Mg. 2 2-cGAMP, Purity:
/=98%, Cas number: 1465774-27-9, Molecular Formula: C20H24N10O13P2, Molecular Weight: 674.4 g/mol, Synonyms: 2,2 -Cyclic GMP-AMP, Adenosine-Guanosine 2,2 -cyclic monophosphate, adenylyl-(2 G 5 )-2 -guanylic acid, Size: 1mg
2 3 Cgamp (Sodium Salt)
/=98% 500Ug. 2 3 cGAMP (sodium salt), Purity:
/=98%, Appearance: solid, A second messenger and inducer of IFN-B production, Synonyms: Adenylyl-(3'G5')-2'-guanylic acid, cyclic nucleotide, disodium salt, Guanosine-Adenosine 2',3'-cyclic monophosphate, Size: 500ug
2 3 Cgamp (Sodium Salt)
/=98% Solid 1Mg. 2 3 cGAMP (sodium salt), Purity:
/=98%, Appearance: solid, A second messenger and inducer of IFN-B production, Synonyms: Adenylyl-(3'G5')-2'-guanylic acid, cyclic nucleotide, disodium salt, Guanosine-Adenosine 2',3'-cyclic monophosphate, Size: 1mg
3 3-Cgamp (Sodium Salt)
/=98% 100Ug. 3 3-cGAMP (sodium salt), Purity:
/=98%, Appearance: Crystalline solid, Second messenger, Synonyms: 3',3'-Cyclic GMP-AMP, Adenosine-Guanosine 3',3'-cyclic monophosphate, Adenylyl-(3'G5')-3'-guanylic acid, cyclic nucleotide, disodium salt, c-GpAp, Size: 100ug
3 3-Cgamp (Sodium Salt)
/=98% 500Ug. 3 3-cGAMP (sodium salt), Purity:
/=98%, Appearance: Crystalline solid, Second messenger, Synonyms: 3',3'-Cyclic GMP-AMP, Adenosine-Guanosine 3',3'-cyclic monophosphate, Adenylyl-(3'G5')-3'-guanylic acid, cyclic nucleotide, disodium salt, c-GpAp, Size: 500ug
Recom Sting R232 Variant Hu
/=80% 100Ug. STING R232 variant human recombinant protein, Purity:
/=80% SDS, Source: Recombinant N-terminal His-tagged STING catalytic domain purified from E.Coli, 138-379aa, Synonyms: Endoplasmic Reticulum Interferon Stimulator, ERIS, hSTING, MITA, MPYS, Size: 100ug
Recom Sting H232 Variant Hu
/=70% 100Ug. STING H232 variant human recombinant protein, Purity:
/=70% SDS-PAGE, Source: Recombinant N-terminal His-tagged STING catalytic domain purified from E.Coli, 138-379aa, Molecular Weight: 28.8 kDa, Synonyms: ERIS, hSTING, MITA, MPYS, Size: 100 ug
Recom Sting H232 Variant Hu
/=95% 50 Ug. STING H232 variant SUMO-tagged human recombinant protein, Purity:
/=95% by SDS PAGE, Source: Recombinant N-terminal histidine- and SUMOpro-tagged protein expressed in E.Coli, MW: 34.5 kDa, Synonyms: Stimulator of Interferon Genes, TMEM173, Size: 50ug
Calcein Am
/= 90% Cas 148504-34-1 500Ug. Calcein AM, a cell-permeable dye that, upon entering live cells, Molecular Formula: C46H46N2O23, Formula Weight: 994.9, CAS No: 148504-34-1, Purity:
/= 90%, Synonyms: Calcein Acetoxymethyl ester, NSC 689290, Form
Bis-Ans (Potassium Salt)
/= 98% 1 Mg. bis-ANS (potassium salt), Purity:
/= 98%, CAS Number: 65664-81-5, Synonym: 4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic Acid, a high-affinity non-covalent extrinsic fluorescent dye, MF: C32H22N2O6S2. 2K, MW: 672.9
Bis-Ans (Potassium Salt)
/= 98% 5 Mg. bis-ANS (potassium salt), Purity:
/= 98%, CAS Number: 65664-81-5, Synonym: 4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic Acid, a high-affinity non-covalent extrinsic fluorescent dye, MF: C32H22N2O6S2. 2K, MW: 672.9
Bis-Ans (Potassium Salt)
/= 98% 10 Mg. bis-ANS (potassium salt), Purity:
/= 98%, CAS Number: 65664-81-5, Synonym: 4,4'-Dianilino-1,1'-binaphthyl-5,5'-disulfonic Acid, a high-affinity non-covalent extrinsic fluorescent dye, MF: C32H22N2O6S2. 2K, MW: 672.
Echinocandin B
/=95% 54651-05-7 5Mg. Echinocandin B, Purity
/=95%, CAS no: 54651-05-7, echinocandin antifungal isolated from Aspergillus, inhibitor of 1,3-B glucan synthase & incorporation of radiolabeled glucose into alkali-insoluble glucan by S. Cerevisiae spheroplasts, Size: 5mg
APOTRACKER GREEN HUMAN MOUSE 20 TESTS - 427401
APOTRACKER GREEN HUMAN MOUSE 100 TESTS - 427402
10MM TRIS-HCL SOLUTIONPH 80 1000ML - T1173
TETRAHYDROZOLINE (HCL) - 23004-5
TETRAHYDROZOLINE (HCL) - 23004-10
OXYMETAZOLINE (HYDROCHLORIDE) - 23826-500
TETRAHYDROZOLINE (HCL) - 23004-1
TETRAHYDROZOLINE (HCL) - 23004-50
OXYMETAZOLINE (HYDROCHLORIDE) - 23826-1
(Z)-HEXADEC-9-ENOIC ACID 1G - A559345-1G
BODI FLUOR 488 AMINE 5MG - 702
TIMP-1, Recombinant Human Protein. Species Reactivity: Human. Applications: Western Blot. Comments: Biologically activity of this product is not determined. Reconstitute in 200 -l PBS.
TIMP-2, Recombinant Human Protein. Species Reactivity: Human. Applications: Western Blot. Comments: CHO cell derived recombinant protein. Migrates as a 24 kDa protein under reducing conditions in SDS-PAGE. Biological activity of this product is not determined. Reconstitute in 200 -l PBS.
TACE, His-Tag, Recombinant Protein. 10ug. Recom. human TACE corres. to aa residues 1-170 w/ His-Tag sequence was expressed in insect cell line Trichoplusia ni. Purified protein exists as two forms:100 kDa proenzyme & mature, 80 kDa active enzyme. Purity
=90% SDS-PAGE. Activity:
=100 pmol/min/mg.
RESISTIN HUMAN RECOMBINANT - PF138-25UG
Flourescent Dye. Calcein AM Fluorescent Dye (10 x 50 mg)
Flourescent Dye. Calcein AM Fluorescent Dye, 1MG
Flourescent Dye. DiIC12(3) Fluorescent Dye, 100MG.
Category
Ambulatory Equipment
Apparel
Appliances (Durable Goods)
Body Pressure Relief and Positioning
Clinical Laboratory
Diagnostic Instruments and Supplies
Drainage and Suction
Furnishings
Gloves
Housekeeping
Implants
Incontinence
Indicators and Signage
Instruments
IV Therapy
Needles and Syringes
Nurse's Station and Office Supplies
Nutritionals and Feeding Supplies
Orthopedic
Ostomy
other
Personal Hygiene
Pharmaceuticals
Physical Therapy
Respiratory
Services
Sterilization
Textiles
Training and Education
Urological
Utensils
Ventilators
Wound Care
Wound Closure
Prev
2
3
4
5
Next